Clinical Trial Detail

NCT ID NCT02334735
Title A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nina Bhardwaj
Indications

melanoma

Therapies

Poly ICLC

Autologous Dendritic Cells Pulsed with MART-1

NY-ESO-1 peptide vaccine

Age Groups: adult

No variant requirements are available.